The product designated as Sihuang Erzhu Powder Veterinary Grade API is a multi-herb botanical powder processed for use as a starting material in seven finished dosage forms: tablets, injections, capsules, powders, granules, premix, and solutions. The botanical source material typically comprises the dried rhizomes, roots, and barks associated with the formula’s four yellow herbs—Rhizoma Coptidis, Radix Scutellariae, Cortex Phellodendri, and Radix et Rhizoma Rhei—together with the two atractylodes components, Rhizoma Atractylodis and Rhizoma Atractylodis Macrocephalae. The term “veterinary grade API” refers not to a single purified molecule but to a milled, sieved, and quality-controlled botanical powder with documentation sufficient for downstream pharmaceutical manufacture under current good manufacturing practice. Model designation is manufacturer-specific and appears as a product code in the certificate of analysis; no harmonized international model number is assigned. Specifications therefore are grade-specific and should be fixed in a supplier quality agreement before scale-up.

What Differentiates a Veterinary Grade Multi-Herb API from Crude Botanical Feed Premix?

The main differentiation is the control of particle size, bioburden, foreign matter, and chromatographic consistency. A crude botanical feed premix may be produced by simple grinding and blending without controlled mesh separation, whereas a veterinary grade API intended for tablet, capsule, injectable, or solution manufacture requires defined powder rheology, documented loss on drying, and batch-to-batch marker consistency. Microbial control follows the pharmaceutical approach rather than feed-grade acceptance: enumeration methods based on USP <61> and USP <62> or equivalent pharmacopoeial chapters are applied, with specific absence criteria for Escherichia coli and Salmonella. Heavy metal risk is evaluated under ICH Q3D or equivalent veterinary pharmacopoeial guidance, with testing by USP <233> where a risk assessment indicates that elemental impurities may arise from soil uptake, drying equipment, or comminution media. The multi-herb fingerprint is not a single-peak assay; acceptance requires a validated chromatographic fingerprint with similarity scoring against an approved reference extract.

Particle size distribution is grade-dependent. Tablet and capsule grades are typically milled through a controlled screen or air-classified to remove fibrous oversize, while premix and granule grades may be coarser but must still pass a uniformity test in the final feed matrix. Laser diffraction per ISO 13320:2020 is preferred over simple sieving when downstream dissolution, blend uniformity, or suspension stability is sensitive to the sub-100 µm fraction. The powder is not supplied as a sterile product, and the injection-grade route therefore requires downstream sterilisation or aseptic filtration. The quality control matrix below summarises the core release areas.

For tablet compression, the blend is rarely suitable for direct compression without prior granulation because the fibrous botanical matrix creates poor die filling and high ejection force. A wet-granulation route in a high-shear mixer followed by fluid-bed drying is commonly used when the dose is high and the tablet weight exceeds the capacity of a direct-compression filler. Lubricant addition with magnesium stearate is kept low, typically 0.25–0.5 wt%, because hydrophobic film formation on botanical particles can delay disintegration and reduce dissolution marker release. Rotary tablet press settings are product-specific, but a precompression force of 2–4 kN and main compression force of 8–14 kN are representative starting points during feasibility studies. Powder flow is evaluated by angle of repose or shear cell; values above 40° usually require glidant addition or granulation.

Injectable Solution Manufacture: Particulate and Endotoxin Control

The injection route imposes the most stringent particle and bioburden control because the starting powder is not inherently sterile. Aqueous extracts or dissolved dispersions intended for injection must be prepared in water for injection, clarified by depth filtration, and then sterile-filtered through a membrane with nominal pore size not exceeding 0.22 µm. If the formula contains colloidal polymers or resinous phytochemical fractions, membrane fouling can occur; a staged filtration train with decreasing pore size is therefore specified. Bacterial endotoxin control follows USP <85> or an equivalent veterinary pharmacopoeial method, and the final solution must also meet particulate matter limits under USP <788> and sterility under USP <71>.

Heat sterilisation is not universally applicable to the intact powder because prolonged autoclave exposure may degrade heat-labile flavonoids and anthraquinone glycosides. Terminal sterilisation of the sealed injectable solution at 121 °C for 15 min may be acceptable only after a thermal-stability study demonstrates marker retention and absence of new degradation peaks. The injection grade is therefore differentiated from tablet or premix grade by a lower bioburden acceptance limit, a documented endotoxin reduction step, and compatibility testing with primary packaging. The product remains a multi-component botanical preparation; pharmacopoeial sterility and pyrogen results do not by themselves demonstrate chemical stability of all constituents.

In capsule filling operations, the tapped density and flow function are more relevant than absolute particle size. Capsule formulations based on Sihuang Erzhu Powder commonly require pre-blending with a free-flowing diluent and the use of a tamping pin or dosator capsule filler with adjustable powder bed height. Powder grades intended for direct oral powders may be dispensed after simple dilution, but blending validation must demonstrate content uniformity with a coefficient of variation below the acceptance limit defined in USP <905> or equivalent. Granule manufacture requires dry or wet granulation to reduce dusting and improve wetting; fluid-bed drying is preferred over tray drying because the lower drying temperature and shorter residence time reduce browning and marker loss. Premix production in feed mills uses ribbon blenders or twin-shaft paddle mixers, and mixer validation must address carryover and sequence flushing because botanical powders can adhere to internal surfaces more strongly than crystalline synthetic additives.

When Dry Granulation Is Preferred Over Direct Compression for This Botanical Blend

Dry granulation is preferred over direct compression when the API fraction is high and the powder exhibits elastic recovery during compaction. Botanical materials with high fibre content tend to laminate because the particles compress by fragmentation and plastic deformation unevenly. Roller compaction with a roll pressure sufficient to form a compact ribbon, followed by screen milling to a defined granule size, reduces the elastic recovery and produces a denser granule with improved flow. The compacted granule is then compressed on a rotary tablet press at lower compression force than would be required for the native powder. Dry granulation avoids the moisture and thermal exposure of wet granulation and is therefore selected when the marker compounds are sensitive to hydrolysis or when the cost of drying would extend the batch cycle. The disadvantage is that dust generation remains higher than with wet granulation, and the resulting tablets may exhibit slower disintegration unless a disintegrant is added intragranularly and extragranularly.

The granulation endpoint is best controlled by granule fracture strength and particle size distribution rather than visual appearance alone. Roller compactors with instrumentation for gap, roll speed, and hydraulic pressure allow real-time monitoring of the ribbon density. Screen milling through a 0.8–1.2 mm screen is a common starting point, but the final sieve fraction is determined by tablet weight, disintegration requirement, and downstream coating adhesion. The process is more sensitive to ambient humidity than synthetic granulations because the hygroscopic polysaccharide fraction can plasticise the granules and increase sticking during compression. Relative humidity above 60% typically requires dehumidified handling areas and low-moisture packaging liners.

Unlike synthetic small-molecule veterinary APIs, Sihuang Erzhu Powder cannot be characterised by a single assay value. The pharmacologically relevant matrix is a mixture of alkaloids, flavonoids, anthraquinones, glycosides, and polysaccharides that vary with plant origin, harvest season, and comminution history. Batch consistency therefore depends on multiple markers and a similarity-limited chromatographic fingerprint rather than an isolated active ingredient. Compared with single-herb APIs, the four-yellow and two-atractylodes combination creates a broader polarity range in the extract, which affects solubility, adsorption onto filter media, and partitioning into granulation binders. Compared with chemically synthesised antimicrobials, the product’s quality profile is closer to a botanical drug substance, and residue depletion cannot be inferred from a single marker. Published species-specific pharmacokinetic and residue depletion data for the complete multi-herb matrix across all seven dosage forms is limited; therefore, in-process marker validation is used for batch consistency, and withdrawal-period claims must be established separately under national veterinary drug regulations.

Where solution forms are required, the powder should be dispersed in a vehicle whose pH and ionic strength are defined during formulation development. Strongly acidic conditions may hydrolyse glycoside linkages, while strongly alkaline conditions can oxidise polyphenolic constituents. Phosphate buffers can precipitate certain alkaloids and should be replaced with a compatible buffer only after physical compatibility testing. For oral solutions, preservative efficacy should be confirmed by USP <51> or equivalent because botanical solutions may support microbial growth if unpreserved. The solution may require filtration through a 1–5 µm clarifying filter before final polishing to remove resinous material that would otherwise foul sterilising-grade membranes. The table below summarises the dosage-route compliance matrix.

Batch records for each route should document the exact grade of Sihuang Erzhu Powder Veterinary Grade API used, its certificate of analysis number, and the processing conditions under which the powder was incorporated. The botanical source and drying history are part of the batch review because they influence the final blend’s moisture, marker content, and microbial load. Equipment surfaces in direct contact with the powder should be dedicated or subject to validated cleaning because resinous phytochemical residues may be difficult to remove from blender seals and filter housings.